Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-23 Sale | 2024-09-24 9:01 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,983,257 | $11.79 | $23,382,600 | 32,843,727 (Direct) | View |
| 2022-10-25 Sale | 2022-10-27 6:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 19,276 | $4.4 | $84,814 | 1,164,009 (Direct) | View |
| 2022-09-23 Sale | 2022-09-27 7:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 21,053 | $3.07 | $64,633 | 1,183,285 (Direct) | View |
| 2022-08-24 Sale | 2022-08-26 7:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 20,009 | $3.71 | $74,233 | 1,204,338 (Direct) | View |
| 2022-07-25 Sale | 2022-07-27 9:08 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 20,455 | $4.33 | $88,570 | 1,224,347 (Direct) | View |
| 2022-06-23 Sale | 2022-06-27 7:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 19,855 | $4.34 | $86,171 | 1,244,802 (Direct) | View |
| 2022-05-20 Sale | 2022-05-24 7:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 139,791 | $3.7 | $517,227 | 1,264,657 (Direct) | View |
| 2022-04-25 Sale | 2022-04-27 7:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 8,509 | $3.84 | $32,675 | 1,404,448 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-20 Tax Withholding | 2024-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.92 | 17,361,059 (Direct) | View |
| 2024-09-20 Tax Withholding | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.97 | 32,843,727 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 9:01 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,550,000 | $0 | 32,843,727 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,550,000 | $3.85 | 32,843,727 (Direct) | View |
| 2024-09-23 Other | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 498,539 | $11.97 | 32,843,727 (Direct) | View |
| 2024-08-20 Tax Withholding | 2024-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,947 | $11.48 | 18,314,745 (Direct) | View |
| 2024-07-26 Option Award | 2024-07-30 9:04 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 17,204,821 | $0 | 18,325,692 (Direct) | View |
| 2024-07-20 Tax Withholding | 2024-07-25 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11 | 1,120,871 (Direct) | View |
| 2024-06-20 Tax Withholding | 2024-06-24 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $10.8 | 1,131,816 (Direct) | View |
| 2024-05-20 Tax Withholding | 2024-05-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.37 | 1,142,761 (Direct) | View |
| 2024-04-20 Tax Withholding | 2024-04-23 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $10.46 | 1,153,706 (Direct) | View |
| 2024-03-30 Tax Withholding | 2024-04-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 215,991 | $10.54 | 1,164,651 (Direct) | View |
| 2024-03-30 Exercise | 2024-04-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 390,579 | $0 | 1,164,651 (Direct) | View |
| 2024-03-30 Exercise | 2024-04-02 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 994,373 | $6.4 | 1,164,651 (Direct) | View |
| 2024-03-20 Tax Withholding | 2024-03-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $10.01 | 990,063 (Direct) | View |
| 2024-02-20 Tax Withholding | 2024-02-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.54 | 1,001,008 (Direct) | View |
| 2024-01-20 Tax Withholding | 2024-01-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $10.35 | 1,011,953 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 38,453 | $0 | 4,195,421 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 47,351 | $11.5 | 4,195,421 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 85,232 | $6.4 | 4,195,421 (Direct) | View |
| 2023-12-27 Tax Withholding | 2023-12-29 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 22,043 | $11.58 | 4,195,421 (Direct) | View |
| 2023-12-20 Tax Withholding | 2023-12-22 7:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $9.96 | 1,006,488 (Direct) | View |
| 2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,318 | $8.68 | 1,028,751 (Direct) | View |
| 2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 12,489 | $8.99 | 1,041,240 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 17,762 | $0 | 4,441,820 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 47,351 | $11.5 | 4,441,820 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 28,411 | $6.4 | 4,441,820 (Direct) | View |
| 2023-09-28 Other | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,243 | $12.67 | 4,441,820 (Direct) | View |
| 2023-09-22 Other | 2023-09-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,227 | $10.19 | 1,044,948 (Direct) | View |
| 2023-08-27 Exercise | 2023-08-29 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 12,088 | $0 | 2,244,979 (Direct) | View |
| 2023-05-27 Exercise | 2023-08-29 9:31 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 28,410 | $6.4 | 2,244,979 (Direct) | View |
| 2023-08-28 Other | 2023-08-29 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 6,784 | $11.25 | 2,244,979 (Direct) | View |
| 2023-08-22 Other | 2023-08-24 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,015 | $10.83 | 1,050,659 (Direct) | View |
| 2023-08-02 Other | 2023-08-03 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,749 | $11.79 | 1,062,408 (Direct) | View |
| 2023-07-27 Exercise | 2023-07-31 9:33 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 23,149 | $0 | 2,198,834 (Direct) | View |
| 2023-07-27 Exercise | 2023-07-31 9:33 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 56,821 | $6.4 | 2,198,834 (Direct) | View |
| 2023-07-24 Other | 2023-07-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,146 | $10.99 | 1,050,405 (Direct) | View |
| 2023-06-22 Other | 2023-06-26 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,863 | $10.01 | 1,061,268 (Direct) | View |
| 2023-05-27 Exercise | 2023-05-31 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 53,281 | $0 | 2,284,781 (Direct) | View |
| 2023-05-31 Other | 2023-05-31 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 30,266 | $9.09 | 2,284,781 (Direct) | View |
| 2023-05-27 Exercise | 2023-05-31 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 170,464 | $6.4 | 2,284,781 (Direct) | View |
| 2023-05-23 Other | 2023-05-25 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 18,972 | $9.58 | 1,057,225 (Direct) | View |
| 2023-04-20 Tax Withholding | 2023-04-24 9:28 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 19,375 | $8.8 | 1,057,225 (Direct) | View |
| 2023-03-23 Other | 2023-03-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 18,563 | $7.3 | 1,095,163 (Direct) | View |
| 2023-02-22 Other | 2023-02-24 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 14,471 | $8.43 | 1,109,634 (Direct) | View |
| 2023-01-24 Other | 2023-01-26 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 15,594 | $8.56 | 1,125,228 (Direct) | View |
| 2022-12-23 Other | 2022-12-28 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 19,408 | $7.1 | 1,144,636 (Direct) | View |
| 2022-11-20 Other | 2022-11-22 6:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 19,373 | $5 | 1,164,009 (Direct) | View |
| 2022-04-20 Option Award | 2022-04-22 7:25 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 16,523,184 | $0 | 16,523,184 (Direct) | View |